LivaNova (LIVN)

Nasdaq Health Care Health Care Equipment S&P MidCap 400
$89.99
-1.15 (-1.26%)
Close of Nov 06, 2026 · end-of-day data
Source: LivaNova's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$964.86M$1.01B$1.11B$1.08B$934.24M$1.04B$1.02B$1.15B$1.25B$1.39B
Cost of revenue$367.85M$353.19M$361.32M$360.37M$339.48M$329.37M$314.58M$397.73M$399.95M$448.18M
Gross profit$559.51M$651.62M$745.64M$723.80M$594.76M$705.99M$707.23M$755.82M$853.48M$939.87M
Research & development$82.08M$109.52M$145.95M$146.85M$152.90M$183.41M$155.81M$193.82M$182.51M$185.76M
Selling, general & admin$355.16M$380.10M$464.97M$528.47M$446.56M$471.90M$469.24M$502.70M$508.88M$548.81M
Operating income$33.45M$96.49M-$248.07M-$171.55M-$273.90M-$784.00K-$76.75M-$68.50M$129.05M$199.39M
Interest expense$10.62M$7.80M$9.82M$15.09M$40.84M$50.15M$48.25M$58.85M$63.07M$49.29M
Pre-tax income$25.67M$121.14M-$247.45M-$188.38M-$348.02M-$124.47M-$75.14M-$81.23M$88.31M-$220.78M
Income tax$5.11M$49.95M-$69.63M-$30.37M-$960.00K$11.20M$11.05M-$98.88M$25.06M$21.64M
Net income-$62.79M-$25.09M-$189.40M-$157.64M-$348.82M-$135.82M-$86.25M$17.55M$63.23M-$242.47M
EBITDA$118.81M$133.54M-$215.33M-$141.24M-$244.87M$23.75M-$54.38M-$43.76M$154.16M$227.95M
EPS (basic)$-1.29$-0.52$-3.91$-3.21$-7.18$-2.68$-1.61$0.33$1.17$-4.45
EPS (diluted)$-1.28$-0.52$-3.91$-3.26$-7.18$-2.68$-1.61$0.32$1.16$-4.45
Diluted shares49.01M48.50M48.50M48.35M48.59M50.63M53.47M54.21M54.57M54.55M
Gross margin58.0%64.4%67.4%66.8%63.7%68.2%69.2%65.5%68.1%67.7%
Operating margin3.5%9.5%-22.4%-15.8%-29.3%-0.1%-7.5%-5.9%10.3%14.4%
Net margin-6.5%-2.5%-17.1%-14.5%-37.3%-13.1%-8.4%1.5%5.0%-17.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$39.79M$93.61M$47.20M$61.14M$252.83M$207.99M$214.17M$266.50M$428.86M$635.55M
Receivables$213.26M$282.14M$256.13M$257.77M$184.36M$185.35M$183.11M$215.07M$193.16M$215.99M
Inventory$133.02M$144.47M$153.53M$164.15M$115.28M$105.84M$129.38M$147.89M$147.57M$164.70M
Total current assets$812.69M$869.86M$533.30M$549.44M$708.04M$679.18M$886.14M$988.16M$1.13B$1.10B
Goodwill$691.71M$784.24M$956.82M$915.79M$922.32M$899.52M$768.79M$782.94M$750.01M$792.84M
Total assets$2.34B$2.50B$2.55B$2.41B$2.40B$2.20B$2.29B$2.43B$2.51B$2.61B
Total current liabilities$349.89M$406.02M$496.75M$512.55M$309.05M$696.97M$297.40M$334.98M$392.12M$808.07M
Short-term debt$47.65M$84.03M$28.79M$77.40M$13.34M$229.67M$23.43M$18.11M$78.00M$31.47M
Long-term debt$75.22M$61.96M$139.54M$260.33M$642.30M$9.85M$518.07M$568.54M$549.62M$345.19M
Total debt$122.86M$145.99M$168.33M$337.73M$655.64M$239.52M$541.50M$586.65M$627.63M$376.66M
Total liabilities$635.72M$688.58M$1.05B$1.03B$1.29B$906.31M$1.09B$1.15B$1.19B$1.41B
Shareholders' equity$1.71B$1.82B$1.50B$1.38B$1.11B$1.29B$1.21B$1.28B$1.32B$1.20B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$90.15M$91.34M$120.49M-$91.14M-$79.42M$102.54M$69.92M$74.91M$183.04M$254.34M
Capital expenditures$38.36M$32.93M$37.19M$24.69M$35.02M$25.48M$26.52M$34.98M$47.11M$81.05M
Free cash flow$51.79M$58.41M$83.30M-$115.83M-$114.45M$77.07M$43.40M$39.93M$135.93M$173.29M
Investing cash flow-$44.52M-$52.85M-$120.56M-$41.29M-$41.84M$36.90M-$38.41M-$40.33M-$48.16M-$72.91M
Financing cash flow-$118.04M$11.29M-$42.35M$146.58M$310.76M-$181.48M$280.13M$21.48M$18.55M-$285.66M
Share buybacks$54.49M$0$50.00M$0$0—————
Stock-based compensation$19.57M$19.06M$26.92M$32.55M$35.09M$40.56M$44.81M$36.35M$33.93M$36.29M
Depreciation & amortization$85.36M$37.05M$32.75M$30.32M$29.03M$24.54M$22.37M$24.74M$25.10M$28.56M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.